Published in J Virol on February 01, 1999
Hostile takeovers: viral appropriation of the NF-kappaB pathway. J Clin Invest (2001) 3.28
Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol (2000) 2.65
The ETS transcription factor GABPalpha is essential for early embryogenesis. Mol Cell Biol (2004) 1.46
Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner. J Virol (2004) 1.34
HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology (2011) 1.17
Effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments. J Virol (2006) 1.16
Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. J Biol Chem (2012) 1.16
A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus. J Virol (1999) 1.06
An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection. J Virol (2012) 1.04
Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins. J Virol (2005) 1.03
NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site. PLoS Pathog (2006) 0.99
HIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo. J Clin Invest (2005) 0.97
The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication. J Virol (2004) 0.95
Crystal structure of NFAT bound to the HIV-1 LTR tandem kappaB enhancer element. Structure (2008) 0.93
Structural basis of HIV-1 activation by NF-kappaB--a higher-order complex of p50:RelA bound to the HIV-1 LTR. J Mol Biol (2009) 0.90
Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-κB. J Virol (2011) 0.87
Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter. Retrovirology (2011) 0.84
Caveolin-1 suppresses human immunodeficiency virus-1 replication by inhibiting acetylation of NF-κB. Virology (2012) 0.83
T-Cell Signaling in HIV-1 Infection. Open Virol J (2013) 0.83
Sequence insertions in the HIV type 1 subtype C viral promoter predominantly generate an additional NF-κB binding site. AIDS Res Hum Retroviruses (2012) 0.83
Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat. Retrovirology (2005) 0.83
Effects of HCV on basal and tat-induced HIV LTR activation. PLoS One (2013) 0.81
Heterogeneity of signal transducer and activator of transcription binding sites in the long-terminal repeats of distinct HIV-1 subtypes. Open Virol J (2007) 0.81
Mutations generated in human immunodeficiency virus type 1 long terminal repeat during vertical transmission correlate with viral gene expression. Virology (2008) 0.80
Recent advances on viral manipulation of NF-κB signaling pathway. Curr Opin Virol (2015) 0.78
Genetic diversity in HIV-1 subtype C LTR from Brazil and Mozambique generates new transcription factor-binding sites. Viruses (2014) 0.77
Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism. J Virol (2005) 0.77
The variances of Sp1 and NF-κB elements correlate with the greater capacity of Chinese HIV-1 B'-LTR for driving gene expression. Sci Rep (2016) 0.76
The sense behind retroviral anti-sense transcription. Virol J (2017) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (1987) 19.23
A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell (1998) 10.14
Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol (1994) 8.98
A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene (1988) 8.40
NF-kappa B: a lesson in family values. Cell (1995) 7.33
Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell (1989) 6.28
Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65. Nature (1991) 5.07
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A (1989) 5.03
Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol Cell Biol (1992) 4.36
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J (1996) 3.92
Identification of Ets- and notch-related subunits in GA binding protein. Science (1991) 3.69
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol (1998) 3.65
The structure of GABPalpha/beta: an ETS domain- ankyrin repeat heterodimer bound to DNA. Science (1998) 3.38
The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J Virol (1989) 3.36
Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol (1992) 2.93
HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science (1996) 2.79
TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors. EMBO J (1989) 2.65
Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro. J Virol (1998) 2.50
Taking a new TAK on tat transactivation. Genes Dev (1997) 2.46
A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes. Mol Cell Biol (1990) 2.22
Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J (1995) 2.10
Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol Cell Biol (1995) 2.07
HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J (1995) 2.01
A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J Virol (1997) 1.91
Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol (1997) 1.82
Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J Virol (1997) 1.71
Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells. EMBO J (1998) 1.62
Gene regulation by Ets proteins. Biochim Biophys Acta (1993) 1.61
The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J Virol (1997) 1.59
Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1. EMBO J (1993) 1.57
Identification of two transcription factors that bind to specific elements in the promoter of the adenovirus early-region 4. Mol Cell Biol (1988) 1.50
Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses. Curr Top Microbiol Immunol (1991) 1.47
Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus. J Virol (1994) 1.41
Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology (1997) 1.39
A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells. J Virol (1992) 1.38
Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter. J Virol (1996) 1.35
The regulation of human immunodeficiency virus type-1 gene expression. Eur J Biochem (1996) 1.25
Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J Virol (1997) 1.17
Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements. J Virol (1992) 1.17
Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism. J Virol (1997) 1.14
Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter. J Virol (1998) 1.06
Oncogene activation of HIV-LTR-driven expression via the NF-kappa B binding sites. Nucleic Acids Res (1993) 1.02
Structural and functional analysis of NF-kappa B. Determinants of DNA binding specificity and protein interaction. J Biol Chem (1994) 1.00
GABP and PU.1 compete for binding, yet cooperate to increase CD18 (beta 2 leukocyte integrin) transcription. J Biol Chem (1995) 0.99
Retinoblastoma binding factor 1 site in the core promoter region of the human RB gene is activated by hGABP/E4TF1. Cancer Res (1997) 0.98
Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity. J Virol (1993) 0.98
ETS family proteins activate transcription from HIV-1 long terminal repeat. AIDS Res Hum Retroviruses (1993) 0.98
Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription. J Biol Chem (1997) 0.98
Intracellular analysis of in vitro modified HIV Tat protein. J Biol Chem (1994) 0.97
The retinoblastoma binding factor 1 (RBF-1) site in RB gene promoter binds preferentially E4TF1, a member of the Ets transcription factors family. Oncogene (1994) 0.97
Ras-responsiveness of the HIV-1 LTR requires RBF-1 and RBF-2 binding sites. Oncogene (1996) 0.95
Regulation of equine infectious anemia virus expression. J Biomed Sci (1998) 0.95
Improved envelope function selected by long-term cultivation of a translation-impaired HIV-1 mutant. Virology (1998) 0.94
Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation. Oncogene (1996) 0.92
Sequence specific binding of the transcription factor c-Ets1 to the human immunodeficiency virus type I long terminal repeat. Biochem Biophys Res Commun (1993) 0.90
Characterization of the human thrombopoietin gene promoter. A possible role of an Ets transcription factor, E4TF1/GABP. J Biol Chem (1997) 0.89
Tat, Tat-associated kinase, and transcription. J Biomed Sci (1998) 0.88
Activation of the retinoblastoma gene expression by Bcl-3: implication for muscle cell differentiation. Oncogene (1996) 0.86
Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science (1991) 4.66
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J (1996) 3.92
MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development (1999) 3.80
Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol (2000) 2.65
MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol (2008) 2.55
Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J Virol (1995) 2.47
Two alternating structures of the HIV-1 leader RNA. RNA (2001) 2.47
Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis (2005) 2.41
Mount st. Helens ash from the 18 may 1980 eruption: chemical, physical, mineralogical, and biological properties. Science (1980) 2.06
p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J Biol Chem (1997) 2.03
A prospective evaluation of the clinical utility of the lower-extremity injury-severity scores. J Bone Joint Surg Am (2001) 1.99
A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J Virol (1999) 1.91
A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J Virol (1997) 1.91
Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase. J Virol (1997) 1.91
Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol (2001) 1.89
Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med (2000) 1.81
Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J (1994) 1.74
Characterization of cDNA for the large subunit of the transcription initiation factor TFIIF. Nature (1992) 1.73
Initiation of HIV-1 reverse transcription is regulated by a primer activation signal. J Biol Chem (2001) 1.71
Assembly of the human T cell receptor-CD3 complex takes place in the endoplasmic reticulum and involves intermediary complexes between the CD3-gamma.delta.epsilon core and single T cell receptor alpha or beta chains. J Biol Chem (1988) 1.68
Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem (2001) 1.61
Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter. J Bacteriol (1995) 1.61
Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins. Antiviral Res (1996) 1.59
Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer (2006) 1.54
Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood (2000) 1.54
Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1990) 1.52
Depth distribution of bacterial production in a stratified lake with an anoxic hypolimnion. Appl Environ Microbiol (1986) 1.50
Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infect Immun (2006) 1.43
Optimization of the Tet-On system for regulated gene expression through viral evolution. Gene Ther (2006) 1.42
Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus. J Virol (1994) 1.41
Helicobacter heilmannii associated erosive gastritis. Intern Med (1999) 1.41
Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J Biol Chem (1998) 1.40
In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc Natl Acad Sci U S A (2001) 1.40
Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model. Gene Ther (2008) 1.40
Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology (1997) 1.39
Requirements for cell surface expression of the human TCR/CD3 complex in non-T cells. Int Immunol (1991) 1.36
The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Res (1999) 1.36
Regulation of HIV expression: mechanisms of action of Tat and Rev. AIDS (1991) 1.31
Metabolic fate of oxidized guanine ribonucleotides in mammalian cells. Biochemistry (1999) 1.30
Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis. Nucleic Acids Res (1994) 1.30
Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1997) 1.28
ATF3 and p15PAF are novel gatekeepers of genomic integrity upon UV stress. Cell Death Differ (2009) 1.27
Ethylene-induced gene expression of osmotin-like protein, a neutral isoform of tobacco PR-5, is mediated by the AGCCGCC cis-sequence. Plant Cell Physiol (1996) 1.27
High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res (2001) 1.27
Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase. Nucleic Acids Res (1997) 1.27
Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology (1992) 1.26
A binding study of the interaction of beta-D-fructose 2,6-bisphosphate with phosphofructokinase and fructose-1,6-bisphosphatase. J Biol Chem (1983) 1.25
Mesp2 initiates somite segmentation through the Notch signalling pathway. Nat Genet (2000) 1.25
Development of a human interleukin-6 receptor antagonist. J Biol Chem (1994) 1.25
The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J Virol (1998) 1.25
Transolecranon fracture-dislocation of the elbow. J Orthop Trauma (1997) 1.24
Determination of the RNA secondary structure that regulates lysis gene expression in bacteriophage MS2. J Mol Biol (1987) 1.24
Effects of integration and replication on transcription of the HIV-1 long terminal repeat. J Biol Chem (1993) 1.22
The effect of template RNA structure on elongation by HIV-1 reverse transcriptase. Biochim Biophys Acta (1999) 1.22
Mechanism of translational coupling between coat protein and replicase genes of RNA bacteriophage MS2. Nucleic Acids Res (1985) 1.20
Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. Eur J Biochem (1991) 1.18
Analysis of shape and retractability of the prepuce in 603 Japanese boys. J Urol (1996) 1.17
Intraarticular "pilon" fracture of the tibia. Clin Orthop Relat Res (1994) 1.17
Effect of the sequences upstream from the ribosome-binding site on the yield of protein from the cloned gene for phage MS2 coat protein. Gene (1983) 1.15
Efficacy of brief coping skills interventions that match different personality profiles of female substance abusers. Psychol Addict Behav (2000) 1.15
The dimer initiation site hairpin mediates dimerization of the human immunodeficiency virus, type 2 RNA genome. J Biol Chem (2001) 1.14
Inhibition of polyadenylation by stable RNA secondary structure. Nucleic Acids Res (1998) 1.14
HIV-1 reverse transcriptase discriminates against non-self tRNA primers. J Mol Biol (1996) 1.14
Inhibiting HIV-1 entry with fusion inhibitors. Curr Med Chem (2003) 1.13
Characterization of patients with high-energy lower extremity trauma. J Orthop Trauma (2001) 1.12
Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem Biophys Res Commun (2001) 1.12
Hif-2alpha mediates UV-induced apoptosis through a novel ATF3-dependent death pathway. Cell Death Differ (2008) 1.11
Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. J Pathol (2007) 1.11
Increased virus replication in mammalian cells by blocking intracellular innate defense responses. Gene Ther (2008) 1.08
Ruptured aneurysm at a duplicated middle cerebral artery with accessory middle cerebral artery. Acta Neurochir (Wien) (2004) 1.07
Sequence variation of the human immunodeficiency virus primer-binding site suggests the use of an alternative tRNA(Lys) molecule in reverse transcription. J Gen Virol (1997) 1.07
A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus. J Virol (1999) 1.06
Resistance to dealing with parents of battered children. Pediatrics (1972) 1.06
Domain structure of a human general transcription initiation factor, TFIIF. Nucleic Acids Res (1993) 1.05
Percutaneous plating in the lower extremity. J Am Acad Orthop Surg (2000) 1.04
Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Histopathology (2003) 1.03
The first strand transfer during HIV-1 reverse transcription can occur either intramolecularly or intermolecularly. Virology (1998) 1.03
Clinical manifestations of human coronavirus NL63 infection in children in Taiwan. Eur J Pediatr (2007) 1.03
Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus. Nucleic Acids Res (1995) 1.03
The PC motif: a novel and evolutionarily conserved sequence involved in interaction between p40phox and p67phox, SH3 domain-containing cytosolic factors of the phagocyte NADPH oxidase. Eur J Biochem (1998) 1.03
Human immunodeficiency virus uses tRNA(Lys,3) as primer for reverse transcription in HeLa-CD4+ cells. FEBS Lett (1994) 1.02
The tendency of lentiviral open reading frames to become A-rich: constraints imposed by viral genome organization and cellular tRNA availability. J Mol Evol (1995) 1.02
Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA. Nucleic Acids Res (2001) 1.02
A structured RNA motif is involved in correct placement of the tRNA(3)(Lys) primer onto the human immunodeficiency virus genome. J Virol (2000) 1.02
Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence. J Clin Pathol (2004) 1.01
Botanical and geological significance of potassium-argon dates from the juan fernandez islands. Science (1984) 1.00
HIV-1 evolves into a nonsyncytium-inducing virus upon prolonged culture in vitro. Virology (1999) 1.00
Extracellular matrix remodeling in the vascular wall. Pathol Biol (Paris) (2001) 1.00
The role of the codon and the initiation factor IF-2 in the selection of N-blocked aminoacyl-tRNA for initiation. Eur J Biochem (1980) 1.00
Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription. Nucleic Acids Res (2000) 0.99
Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells. Oncogene (2011) 0.99
Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. J Gen Virol (1998) 0.99
RNA interference: its use as antiviral therapy. Handb Exp Pharmacol (2006) 0.99
Differences in kinetic properties of phospho and dephospho forms of fructose-6-phosphate, 2-kinase and fructose 2,6-bisphosphatase. J Biol Chem (1984) 0.98
The flowering locus Hr colocalizes with a major QTL affecting winter frost tolerance in Pisum sativum L. Theor Appl Genet (2008) 0.98
Transcriptional regulation of Mesp1 and Mesp2 genes: differential usage of enhancers during development. Mech Dev (2001) 0.98